Meeting Regulatory Requirements for Drugs with a Narrow Therapeutic Index: Bioequivalence Studies of Generic Once-Daily Tacrolimus

Despite growing clinical confidence in generics and their potential to reduce long-term healthcare costs, the transplant community have had real concerns about the use of generic immunosuppressants. One such immunosuppressant is tacrolimus, a cornerstone of lifelong treatment for patients who have u...

Descripción completa

Detalles Bibliográficos
Autores principales: Gantar, Kaja, Škerget, Katja, Mochkin, Ilya, Bajc, Aleksander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489937/
https://www.ncbi.nlm.nih.gov/pubmed/32982466
http://dx.doi.org/10.2147/DHPS.S256455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489937/
https://www.ncbi.nlm.nih.gov/pubmed/32982466
http://dx.doi.org/10.2147/DHPS.S256455

Ejemplares similares